Lauren King
Family · Mobile, ALNPI 1437724861
Payments from drug & device makers
Across 32 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$86
- Amgen$66
- AstraZeneca$55
- Tersera Therapeutics LLC$36
- Bayer$32
- Mirati Therapeutics, Inc.$31
- plus $263 from 14 others
What the payments were for
- Food & beverage$569100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 5 | $86 |
| Amgen | 4 | $66 |
| AstraZeneca | 3 | $55 |
| Tersera Therapeutics LLC | 2 | $36 |
| Bayer | 2 | $32 |
| Mirati Therapeutics, Inc. | 2 | $31 |
| Tempus AI, Inc | 1 | $26 |
| Novartis | 1 | $24 |
| Exelixis Inc. | 1 | $22 |
| Seagen Inc. | 1 | $22 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $17 |
| Sobi, Inc | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Merck | 1 | $14 |
| AVEO Pharmaceuticals, Inc. | 1 | $14 |
| Bioventus LLC | 1 | $14 |
How this compares
$569 in reported general payments places this provider in the 55th percentile of 3,415 family providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 13 | $13,931 |
Paid to pharmacies, not to this prescriber.
Other family in Mobile
- Christopher LovellMobile$64K
- Sanjyot BhadkamkarMobile$16K
- Freda SmithMobile$14K
- Alexandria HellmichMobile$13K
- Kara BoutwellMobile$12K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.